<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The clinical syndrome idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (IIH), also termed <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>, consists of symptoms of <z:hpo ids='HP_0002315'>headache</z:hpo>, <z:hpo ids='HP_0002018'>nausea</z:hpo>, <z:hpo ids='HP_0002013'>vomiting</z:hpo> and <z:hpo ids='HP_0001123'>visual field defects</z:hpo> in combination with findings of <z:hpo ids='HP_0001085'>papilledema</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>IIH is more commonly seen in overweight women where the rise in intracranial pressure is putatively a consequence of an <z:chebi fb="32" ids="24621">endocrine</z:chebi>-based disturbance of electrolytes </plain></SENT>
<SENT sid="2" pm="."><plain>Less frequently, it can also occur in men and in the pediatric age group </plain></SENT>
<SENT sid="3" pm="."><plain>Associated risk factors include primary and <z:e sem="disease" ids="C0271728" disease_type="Disease or Syndrome" abbrv="">secondary aldosteronism</z:e>, pregnancy, recombinant growth hormone (r-GH) therapy, oral contraceptives, <z:hpo ids='HP_0001513'>obesity</z:hpo>, vitamin A intoxication or deficiency, <z:hpo ids='HP_0008207'>Addison disease</z:hpo>, <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> therapy or <z:hpo ids='HP_0011009'>acute</z:hpo> withdrawal of steroid therapy and <z:e sem="disease" ids="C0221406" disease_type="Disease or Syndrome" abbrv="">Cushing disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Herein, we review the association between these conditions and IIH working toward its having a unifying neuroendocrine hypothesis </plain></SENT>
</text></document>